Adenosine A2B receptors.

Adenosine is an endogenous nucleoside that modulates many physiological processes. Its actions are mediated by interaction with specific cell membrane receptors. Four subtypes of adenosine receptors have been cloned: A1, A2A, A2B, and A3. Significant advancement has been made in the understanding of

[1]  M. Williams,et al.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. , 1992, Journal of medicinal chemistry.

[2]  S. Holgate,et al.  Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. , 1995, American journal of respiratory and critical care medicine.

[3]  V. Tkachuk,et al.  A Gs protein couples P2-purinergic stimulation to cardiac Ca channels without cyclic AMP production , 1992, The Journal of general physiology.

[4]  J. Dobson,et al.  Adenosine A2 receptor function in rat ventricular myocytes. , 1997, Cardiovascular research.

[5]  D. Westfall,et al.  Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. , 1994, Pharmacological reviews.

[6]  D. Mogul,et al.  A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus , 1997, Brain Research.

[7]  D. Marquardt,et al.  Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. , 1994, Journal of immunology.

[8]  J. Phillis,et al.  Adenosine receptor subtypes in the brainstem mediate distinct cardiovascular response patterns , 1991, Brain Research Bulletin.

[9]  B. Fredholm,et al.  Adenosine analogues stimulate cyclic AMP-accumulation in cultured neuroblastoma and glioma cells. , 2009, Acta pharmacologica et toxicologica.

[10]  J. Daval,et al.  Adenosine physiology and pharmacology: how about A2 receptors? , 1996, Pharmacology & therapeutics.

[11]  M. Hall,et al.  Stimulation of A2 adenosine receptors inhibits the ingestion of photoreceptor outer segments by retinal pigment epithelium. , 1994, Investigative ophthalmology & visual science.

[12]  A. Tucker,et al.  Cloned receptors and cardiovascular responses to adenosine. , 1993, Cardiovascular research.

[13]  D. Marquardt,et al.  Modulation of mast cell responses to adenosine by agents that alter protein kinase C activity. , 1990, Biochemical pharmacology.

[14]  Syed Jamal Mustafa,et al.  Adenosine receptor-mediated bronchoconstriction and bronchial hyperresponsiveness in allergic rabbit model. , 1994, The American journal of physiology.

[15]  P. Routledge,et al.  Bronchospasm Induced by Intravenous Adenosine , 1994, Human & experimental toxicology.

[16]  S. Holgate,et al.  Specific antagonism of adenosine-induced bronchoconstriction in asthma by oral theophylline. , 1985, British journal of clinical pharmacology.

[17]  B. Fredholm,et al.  Pharmacology of adenosine A2A receptors. , 1996, Trends in pharmacological sciences.

[18]  E. Ongini,et al.  Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes , 1996, British journal of pharmacology.

[19]  R. Berne,et al.  The cardiac effects of adenosine. , 1989, Progress in cardiovascular diseases.

[20]  J. Ribeiro,et al.  Adenosine A2 receptor-mediated excitatory actions on the nervous system , 1996, Progress in Neurobiology.

[21]  T. Iwamoto,et al.  Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.

[22]  K. Jacobson,et al.  A [3H]amine congener of 1,3‐dipropyl‐8‐phenylxanthine , 1986, FEBS letters.

[23]  S. Hourani,et al.  Adenosine analogues relax guinea-pig taenia caeci via an adenosine A2B receptor and a xanthine-resistant site. , 1997, European journal of pharmacology.

[24]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[25]  J. Zwiller,et al.  5′‐(N‐Ethylcarboxamido)adenosine Inhibits Ca2+ Influx and Activates a Protein Phosphatase in Bovine Adrenal Chromaffin Cells , 1995, Journal of neurochemistry.

[26]  I. Biaggioni,et al.  Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. , 1995, The Journal of clinical investigation.

[27]  Y. Chern,et al.  Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. , 1993, Molecular pharmacology.

[28]  B. Liang,et al.  Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation. , 1995, Circulation research.

[29]  T. Dunwiddie,et al.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. , 1989, The Journal of pharmacology and experimental therapeutics.

[30]  E. Tsai,et al.  Adenosine modulation of neurotransmission in penile erection. , 1994, British journal of clinical pharmacology.

[31]  J. Mallol,et al.  The Adenosine Receptors Present on the Plasma Membrane of Chromaffin Cells Are of the A2b Subtype , 1992, Journal of neurochemistry.

[32]  B. Fredholm,et al.  Dual effects of protein kinase-C on receptor-stimulated cAMP accumulation in a human T-cell leukemia line. , 1989, European journal of pharmacology.

[33]  A. Sollevi,et al.  Controlled Hypotension with Adenosine in Cerebral Aneurysm Surgery , 1984, Anesthesiology.

[34]  R. North,et al.  Functional expression of adenosine A2b receptor in Xenopus oocytes. , 1993, Molecular pharmacology.

[35]  A. Balmforth,et al.  Adenosine receptor-induced cAMP changes in D384 astrocytoma cells and the effect of bradykinin thereon. , 1992, Acta physiologica Scandinavica.

[36]  Stephen P. H. Alexander,et al.  Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells , 1996, British journal of pharmacology.

[37]  G. Lu,et al.  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. , 1986, Molecular pharmacology.

[38]  P. Svenningsson,et al.  Glucocorticoids regulate the expression of adenosine A1 but not A(2A) receptors in rat brain. , 1997, Journal of Pharmacology and Experimental Therapeutics.

[39]  P. Singh,et al.  The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonist , 1995, British journal of pharmacology.

[40]  A. Szent-Györgyi,et al.  The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1 , 1929, The Journal of physiology.

[41]  S. Hourani,et al.  Characterization of P1‐purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae , 1996, British journal of pharmacology.

[42]  I. Biaggioni,et al.  Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes. , 1998, Biochemical pharmacology.

[43]  A. Gubitz,et al.  Tissue distribution of adenosine receptor mRNAs in the rat , 1996, British journal of pharmacology.

[44]  J. Downey,et al.  Adenosine-induced vasodilation: receptor characterization in pulmonary circulation. , 1995, The American journal of physiology.

[45]  D. Ukena,et al.  Effects of enprofylline on A1 and A2 adenosine receptors. , 1985, European journal of pharmacology.

[46]  M. Ueeda,et al.  2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. , 1993, The Journal of pharmacology and experimental therapeutics.

[47]  M. Yen,et al.  40 Partially endothelium‐dependent vasodilatory effect of adenosine in rat aorta , 1988, Hypertension.

[48]  L. Hösli,et al.  Autoradiographic studies on the uptake of adenosine and on binding of adenosine analogues in neurons and astrocytes of cultured rat cerebellum and spinal cord , 1988, Neuroscience.

[49]  M. Adams,et al.  Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons , 1993, Neuron.

[50]  R. Furchgott.  The role of endothelium in the responses of vascular smooth muscle to drugs. , 1984, Annual review of pharmacology and toxicology.

[51]  G. Burnstock,et al.  Contribution of P1 (A2b subtype) and P2‐purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed , 1995, British journal of pharmacology.

[52]  A Sattin,et al.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. , 1970, Molecular pharmacology.

[53]  A. Lawrence,et al.  Presynaptic adenosine A2a receptors on soma and central terminals of rat vagal afferent neurons , 1994, Brain Research.

[54]  J. Linden.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. , 1994, Trends in pharmacological sciences.

[55]  G Burnstock,et al.  Towards a revised nomenclature for P1 and P2 receptors. , 1997, Trends in pharmacological sciences.

[56]  C. Blazynski.  Characterization of adenosine A2 receptors in bovine retinal pigment epithelial membranes. , 1993, Experimental eye research.

[57]  T. Sullivan,et al.  Potentiation of mast cell mediator release by adenosine. , 1978, Journal of immunology.

[58]  K. Mullane,et al.  Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury. , 1993, Cardiovascular research.

[59]  T. Palmer,et al.  Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. , 1997, Biochemistry.

[60]  K. Jacobson,et al.  6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists. , 1996, Journal of medicinal chemistry.

[61]  S. Holgate,et al.  Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma. , 1987, Thorax.

[62]  A. Brown,et al.  Alpha-subunit of Gs directly activates cardiac calcium channels in lipid bilayers. , 1988, The American journal of physiology.

[63]  R. Sunahara,et al.  Transcription of a human dopamine D5 pseudogene. , 1991, Biochemical and biophysical research communications.

[64]  T. Knudsen,et al.  Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor. , 1995, Molecular pharmacology.

[65]  B. Fredholm,et al.  Alpha-adrenoceptor stimulation, but not muscarinic stimulation, increases cyclic AMP accumulation in brain slices due to protein kinase C mediated enhancement of adenosine receptor effects. , 1987, Acta physiologica Scandinavica.

[66]  J. Shine,et al.  Molecular cloning and expression of an adenosine A2b receptor from human brain. , 1992, Biochemical and biophysical research communications.

[67]  M. Parmentier,et al.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. , 1991, The EMBO journal.

[68]  I. Biaggioni.  Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. , 1992, Hypertension.

[69]  J. Bauer,et al.  Adenosine A2b Receptors Mediate an Increase in Interleukin (IL)‐6 mRNA and IL‐6 Protein Synthesis in Human Astroglioma Cells , 1996, Journal of neurochemistry.

[70]  J. Balwierczak,et al.  CGS 21680 : a potent selective adenosine A2 receptor agonist , 1992 .

[71]  S. Hill,et al.  Adenosine A1 receptor-mediated inhibition of cyclic AMP accumulation in type-2 but not type-1 rat astrocytes. , 1996, European journal of pharmacology.

[72]  D. Paton.  Structure-activity relations for presynaptic inhibition of noradrenergic and cholinergic transmission by adenosine: evidence for action on A1 receptors. , 1981, Journal of autonomic pharmacology.

[73]  R. F. Bruns,et al.  Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. , 1981, Biochemical pharmacology.

[74]  M. Simon,et al.  G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[75]  I. Biaggioni,et al.  Role of adenosine in asthma , 1996, Drug development research.

[76]  P. L. Martin,et al.  The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine. , 1994, The Journal of pharmacology and experimental therapeutics.

[77]  T. Bonner,et al.  Definition of pharmacological receptors. , 1992, Pharmacological reviews.

[78]  J. Daly,et al.  Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. , 1994, Biochemical pharmacology.

[79]  S. Rees,et al.  G16 as a universal G protein adapter: implications for agonist screening strategies. , 1996, Trends in pharmacological sciences.

[80]  L. Williams,et al.  A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. , 1992, The Journal of biological chemistry.

[81]  K. Jacobson,et al.  A binding site model and structure-activity relationships for the rat A3 adenosine receptor. , 1994, Molecular pharmacology.

[82]  K. Jacobson,et al.  Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors , 1996, Drug development research.

[83]  A. Tucker,et al.  Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution. , 1993, Molecular pharmacology.

[84]  S. Hourani,et al.  Activation of multiple sites by adenosine analogues in the rat isolated aorta , 1996, British journal of pharmacology.

[85]  B. Fredholm.  Purinoceptors in the nervous system. , 1995, Pharmacology & toxicology.

[86]  G. Stiles,et al.  Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. , 1994, The Journal of biological chemistry.

[87]  K. Jacobson,et al.  Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors. , 1996, The Journal of clinical investigation.

[88]  M. Williams,et al.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[89]  E. Ongini,et al.  Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261. , 1996, The Journal of pharmacology and experimental therapeutics.

[90]  S Schiffmann,et al.  RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.

[91]  J. Linden.  Structure and function of A 1 adenosine receptors1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[92]  E. Hollingsworth,et al.  An activator of protein kinase C (phorbol‐12‐myristate‐13‐acetate) augments 2‐chloroadenosine‐elicited accumulation of cyclic AMP in guinea pig cerebral cortical particulate preparations , 1985, FEBS letters.

[93]  K. Eagle,et al.  Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patients. , 1989, Chest.

[94]  B. Fredholm,et al.  Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase. , 1993, Cellular signalling.

[95]  J. T. Turner,et al.  Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL. , 1992, The Journal of pharmacology and experimental therapeutics.

[96]  P. Hughes,et al.  Studies on the receptor mediating cyclic AMP‐independent enhancement by adenosine of IgE‐dependent mediator release from rat mast cells , 1986, British journal of pharmacology.

[97]  Syed Jamal Mustafa,et al.  Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[98]  L. Hendeles,et al.  Theophylline in asthma. , 1996, The New England journal of medicine.

[99]  H. Rajaniemi,et al.  Expression of the LH/CG receptor gene in rat ovarian tissue is regulated by an extensive alternative splicing of the primary transcript , 1992, Molecular and Cellular Endocrinology.

[100]  B. Fredholm,et al.  Activation of protein kinase C and elevation of cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat cells. , 1992, European journal of pharmacology.

[101]  S. Mundell,et al.  A dominant negative mutant of the G protein-coupled receptor kinase 2 selectively attenuates adenosine A2 receptor desensitization. , 1997, Molecular pharmacology.

[102]  B. Fredholm,et al.  Stimulation of T-cells with OKT3 antibodies increases forskolin binding and cyclic AMP accumulation. , 1990, Cellular signalling.

[103]  P. Aas,et al.  Prejunctional stimulation of cholinergic nerves in rat airway smooth muscle by an adenosine analogue. , 1991, Pulmonary pharmacology.

[104]  N. Levens,et al.  Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor. , 1991, The Journal of pharmacology and experimental therapeutics.

[105]  S. Holgate,et al.  Adenosine and asthma , 1986 .

[106]  B. Canning,et al.  Adenosine receptor‐mediated contraction and relaxation of guinea‐pig isolated tracheal smooth muscle: effects of adenosine antagonists , 1988, British journal of pharmacology.

[107]  G. Firestein,et al.  Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. , 1996, Arthritis and rheumatism.

[108]  K. Jacobson,et al.  A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. , 1992, Molecular pharmacology.

[109]  E. Jackson,et al.  Smooth muscle cell-derived adenosine inhibits cell growth. , 1996, Hypertension.

[110]  A. Buist,et al.  Twenty year trends in hospital discharges for asthma among members of a health maintenance organization. , 1992, Journal of clinical epidemiology.

[111]  S. Holgate,et al.  The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5'-monophosphate, and allergen in atopic nonasthmatic subjects. , 1990, The American review of respiratory disease.

[112]  K. Jacobson,et al.  Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. , 1996, Journal of medicinal chemistry.

[113]  P. Gebicke-haerter,et al.  Cyclooxygenase‐2 expression in rat microglia is induced by adenosine A2a‐receptors , 1996, Glia.

[114]  G. Stiles,et al.  The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. , 1993, The Journal of biological chemistry.

[115]  M. Simon,et al.  Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Murray,et al.  Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells. , 1994, Molecular pharmacology.

[117]  D. Cooper,et al.  Subclasses of external adenosine receptors. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[118]  S. Holgate,et al.  The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. , 1987, The American review of respiratory disease.

[119]  M. Jacobson,et al.  Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene. , 1995, Genomics.

[120]  B. Liang,et al.  Characterization of a stimulatory adenosine A2a receptor in adult rat ventricular myocyte. , 1996, The American journal of physiology.

[121]  E. Ongini,et al.  Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes. , 1996, Circulation research.

[122]  M. Simon,et al.  Gα15 and Gα16 Couple a Wide Variety of Receptors to Phospholipase C (*) , 1995, The Journal of Biological Chemistry.

[123]  J. Schrader,et al.  Turnover of adenosine in plasma of human and dog blood. , 1989, The American journal of physiology.

[124]  D K Wagener,et al.  Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. , 1993, Annual review of public health.

[125]  J. Daly,et al.  The nature of receptors regulating the formation of cyclic AMP in brain tissue. , 1976, Life sciences.

[126]  J. N. Wells,et al.  A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding. , 1994, Molecular pharmacology.

[127]  A. Kosar,et al.  Adenosine: a new agent in the diagnosis of impotence. , 1994, International journal of impotence research.

[128]  L. Schwartz,et al.  Tryptase, a mediator of human mast cells. , 1990, The Journal of allergy and clinical immunology.

[129]  E. Jackson,et al.  Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. , 1996, Hypertension.

[130]  S. Schiffmann,et al.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.

[131]  K. Jacobson,et al.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. , 1991, Molecular pharmacology.

[132]  R. Breyer,et al.  Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells. , 1997, Biochemical pharmacology.

[133]  M. Okada,et al.  Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum , 1996, Neuroscience Letters.

[134]  S. Holgate,et al.  Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5'-monophosphate. , 1989, The European respiratory journal.

[135]  S. Holgate,et al.  Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. , 1984, The American review of respiratory disease.

[136]  R. Mrsny,et al.  5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. , 1993, The Journal of clinical investigation.

[137]  R. Berne,et al.  Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. , 1990, The American journal of physiology.

[138]  J. Phillis,et al.  Potassium-evoked efflux of transmitter amino acids and purines from rat cerebral cortex , 1993, Brain Research Bulletin.

[139]  J. Nyce,et al.  DNA antisense therapy for asthma in an animal model , 1997, Nature.

[140]  K. Maekawa,et al.  Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia , 1994 .

[141]  B. Fredholm,et al.  Glucocorticoid receptor activation leads to up-regulation of adenosine A1 receptors and down-regulation of adenosine A2 responses in DDT1 MF-2 smooth muscle cells. , 1991, Molecular pharmacology.

[142]  S. Hill,et al.  Adenosine A2B‐receptor‐mediated cyclic AMP accumulation in primary rat astrocytes , 1994, British journal of pharmacology.

[143]  S. Reppert,et al.  The A Adenosine Receptor Mediates cAMP Responses to Adenosine Receptor Agonists in Human Intestinal Epithelia (*) , 1995, The Journal of Biological Chemistry.

[144]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[145]  X. Ji,et al.  Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. , 1994, Journal of medicinal chemistry.

[146]  S. Rivkees,et al.  RFL9 encodes an A2b-adenosine receptor. , 1992, Molecular endocrinology.

[147]  T. Dunwiddie,et al.  Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. , 1990, The Journal of pharmacology and experimental therapeutics.

[148]  W. Schmitz,et al.  Pertussis toxin unmasks stimulatory myocardial A2-adenosine receptors on ventricular cardiomyocytes. , 1993, Journal of molecular and cellular cardiology.

[149]  R. Olsson.  Adenosine receptors in the cardiovascular system , 1996 .

[150]  M. Lagarde,et al.  Evidence for adenosine A2b receptors in the rat pineal gland. , 1992, European journal of pharmacology.

[151]  G. Burnstock.  A basis for distinguishing two types of purinergic receptor , 1978 .

[152]  M. Norris,et al.  Preoxygenation for cesarean section: a comparison of two techniques. , 1984, Anesthesiology.

[153]  E. Ongini,et al.  The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. , 1996, The Journal of pharmacology and experimental therapeutics.

[154]  M. Verani,et al.  Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. , 1990, Circulation.

[155]  G. Rubanyi,et al.  Endothelium‐Removal Decreases Relaxations of Canine Coronary Arteries Caused by β‐Adrenergic Agonists and Adenosine , 1985, Journal of cardiovascular pharmacology.

[156]  K. Fuxe,et al.  Neuropharmacology of the adenosine A2A receptors , 1996 .

[157]  M. Edbrooke,et al.  Cloning and characterisation of the human adenosine A3 receptor gene , 1996, FEBS letters.

[158]  G. Ghai,et al.  Evidence for A1 and A2 adenosine receptors in guinea pig trachea. , 1987, Life sciences.

[159]  J. Phillis,et al.  Effect of adenosine receptor agonists on spontaneous and K+-evoked acetylcholine release from the in vivo rat cerebral cortex , 1993, Brain Research.

[160]  Brian Seonghwa Lee,et al.  Characterization and ontogeny of P1‐purinoceptors on rat vas deferens , 1993, British journal of pharmacology.

[161]  I. Biaggioni,et al.  Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes. , 1993, Molecular pharmacology.

[162]  L. Lichtenstein,et al.  Differential regulation of human basophil and lung mast cell function by adenosine. , 1991, The Journal of pharmacology and experimental therapeutics.

[163]  L. Kuo,et al.  Endothelial cell calcium increases during flow-induced dilation in isolated arterioles. , 1993, The American journal of physiology.

[164]  P. Schofield,et al.  Localization of the adenosine A2b receptor subtype gene (ADORA2B) to chromosome 17p11.2-p12 by FISH and PCR screening of somatic cell hybrids. , 1995, Genomics.

[165]  Y. Sugimoto,et al.  Molecular mechanisms of diverse actions of prostanoid receptors. , 1995, Biochimica et biophysica acta.

[166]  J. Morley,et al.  A New Cyclic AMP-independent, Gs-mediated Stimulatory Mechanism via the Adenosine A2a Receptor in the Intact Cardiac Cell* , 1996, The Journal of Biological Chemistry.

[167]  S. Rivkees,et al.  Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. , 1992, Molecular endocrinology.

[168]  J. Linden,et al.  Molecular cloning and characterization of the human A3 adenosine receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[169]  A. Wakade,et al.  Inhibition of noradrenaline release by adenosine. , 1978, The Journal of physiology.

[170]  M. Olah.  Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS , 1997, The Journal of Biological Chemistry.

[171]  K. Maekawa,et al.  Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. , 1994, The American journal of physiology.

[172]  C. C. Davis,et al.  Coronary vasoactivity of adenosine covalently linked to polylysine. , 1977, Life sciences.

[173]  P. Svenningsson,et al.  Adenosine (P1) receptor signalling , 1996 .

[174]  S. Dahlén,et al.  Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. , 1992, The American review of respiratory disease.

[175]  S. Macdonald,et al.  Adenosine receptor coupling to adenylate cyclase of rat ventricular myocyte membranes. , 1989, The American journal of physiology.

[176]  Xiaowei Jin,et al.  Molecular characterization of recombinant human adenosine receptors , 1996 .

[177]  P. Gergen,et al.  National survey of prevalence of asthma among children in the United States, 1976 to 1980. , 1988, Pediatrics.

[178]  I. Coupar,et al.  Functional characterization of the adenosine receptor mediating inhibition of intestinal secretion , 1995, British journal of pharmacology.

[179]  D. Robertson,et al.  Cardiovascular Excitatory Effects of Adenosine in the Nucleus of the Solitary Tract , 1991, Hypertension.

[180]  G. Lynch,et al.  Factors regulating the magnitude of long-term potentiation induced by theta pattern stimulation , 1992, Brain Research.

[181]  P. Martin.  Relative agonist potencies of C2-substituted analogues of adenosine: evidence for adenosine A2B receptors in the guinea pig aorta. , 1992, European journal of pharmacology.

[182]  Margarete Müller,et al.  ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS , 1979, Journal of neurochemistry.

[183]  K. Jacobson,et al.  Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. , 1996, Journal of medicinal chemistry.

[184]  B. Fredholm,et al.  Inhibition by xanthine derivatives of adenosine receptor‐stimulated cyclic adenosine 3′, 5′‐monophosphate accumulation in rat and guinea‐pig thymocytes , 1983, British journal of pharmacology.

[185]  K. Jacobson,et al.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations. , 1992, Molecular pharmacology.

[186]  R. Faull,et al.  Neuroprotective effects of adenosine. , 1988, Trends in pharmacological sciences.

[187]  E. Jackson,et al.  Caffeine potentiates vasodilator-induced renin release. , 1991, The Journal of pharmacology and experimental therapeutics.

[188]  G. Stiles,et al.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[189]  A. Mendonça,et al.  Endogenous adenosine modulates long-term potentiation in the hippocampus , 1994, Neuroscience.

[190]  R. A. Johnson,et al.  Potent adenosine receptor antagonists that are selective for the A1 receptor subtype. , 1987, Molecular pharmacology.

[191]  M. Miller,et al.  Comparative effects of a selective adenosine A2 receptor agonist, CGS 21680, and nitroprusside in vascular smooth muscle. , 1991, European journal of pharmacology.

[192]  J. Grider,et al.  Adenosine A1 and A2b receptors coupled to distinct interactive signaling pathways in intestinal muscle cells. , 1995, The Journal of pharmacology and experimental therapeutics.

[193]  I. Biaggioni,et al.  Purinergic receptors in the brainstem mediate hypotension and bradycardia. , 1988, Hypertension.

[194]  B. Fredholm,et al.  Mitogen stimulation of T-cells increases c-Fos and c-Jun protein levels, AP-1 binding and AP-1 transcriptional activity. , 1992, Cellular signalling.